- Home
- APLT vs GLV Comparison
APLT vs GLV Comparison
Compare APLT & GLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- GLV
- Stock Information
- Founded
- APLT 2016
- GLV 2004
- Country
- APLT United States
- GLV United States
- Employees
- APLT N/A
- GLV N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- GLV Finance/Investors Services
- Sector
- APLT Health Care
- GLV Finance
- Exchange
- APLT Nasdaq
- GLV Nasdaq
- Market Cap
- APLT 69.0M
- GLV 71.5M
- IPO Year
- APLT 2019
- GLV N/A
- Fundamental
- Price
- APLT $0.51
- GLV $5.74
- Analyst Decision
- APLT Buy
- GLV
- Analyst Count
- APLT 6
- GLV 0
- Target Price
- APLT $6.10
- GLV N/A
- AVG Volume (30 Days)
- APLT 893.4K
- GLV 54.2K
- Earning Date
- APLT 08-13-2025
- GLV 01-01-0001
- Dividend Yield
- APLT N/A
- GLV 12.44%
- EPS Growth
- APLT N/A
- GLV N/A
- EPS
- APLT N/A
- GLV N/A
- Revenue
- APLT $121,000.00
- GLV N/A
- Revenue This Year
- APLT $415.60
- GLV N/A
- Revenue Next Year
- APLT $1,323.96
- GLV N/A
- P/E Ratio
- APLT N/A
- GLV N/A
- Revenue Growth
- APLT N/A
- GLV N/A
- 52 Week Low
- APLT $0.30
- GLV $4.70
- 52 Week High
- APLT $10.62
- GLV $6.06
- Technical
- Relative Strength Index (RSI)
- APLT 61.88
- GLV 57.82
- Support Level
- APLT $0.47
- GLV $5.62
- Resistance Level
- APLT $0.53
- GLV $5.79
- Average True Range (ATR)
- APLT 0.03
- GLV 0.05
- MACD
- APLT 0.00
- GLV -0.01
- Stochastic Oscillator
- APLT 83.33
- GLV 70.59
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About GLV Clough Global Dividend and Income Fund of beneficial interest
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.